NCT01679002View on ClinicalTrials.gov

Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Epilepsy
Interventions
DRUG

BIA 2-093

DRUG

Oxcarbazepine

Trial Locations (1)

4745-457

BIAL - Portela & Cª S.A. - Human Pharmacology Unit (UFH), S. Mamede Do Coronado

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT01679002 - Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers | Biotech Hunter | Biotech Hunter